Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Surv Ophthalmol. 2021 Nov-Dec;66(6):1031-1050. doi: 10.1016/j.survophthal.2021.02.011. Epub 2021 Mar 4.
Congenital aniridia is a rare genetic eye disorder with total or partial absence of the iris from birth. In most cases the genetic origin of aniridia is a mutation in the PAX6 gene, leading to involvement of most eye structures. Hypoplasia of the fovea is usually present and is associated with reduced visual acuity and nystagmus. Aniridia-associated keratopathy, glaucoma, and cataract are serious and progressive complications that can further reduce visual function. Treatment of the ocular complications of aniridia is challenging and has a high risk of side effects. New approaches such as stem cell therapy may, however, offer better prognoses. We describe the various ocular manifestations of aniridia, with a special focus on conditions that commonly require treatment. We also review the growing literature reporting systemic manifestations of the disease.
先天性无虹膜是一种罕见的遗传性眼部疾病,出生时虹膜完全或部分缺失。在大多数情况下,无虹膜的遗传起源是 PAX6 基因突变,导致大多数眼部结构受累。黄斑发育不良通常存在,并伴有视力下降和眼球震颤。无虹膜相关的角膜病变、青光眼和白内障是严重且进行性的并发症,可进一步降低视力。无虹膜眼部并发症的治疗具有挑战性,且副作用风险高。然而,干细胞治疗等新方法可能提供更好的预后。我们描述了无虹膜的各种眼部表现,特别关注那些通常需要治疗的情况。我们还回顾了越来越多的关于该疾病全身表现的文献报道。